Nancy A. Grygiel is senior vice president, Worldwide Compliance & Business Ethics and chief compliance officer at Amgen.

Grygiel is responsible for driving a culture of integrity and business ethics at Amgen worldwide. She leads multiple compliance programs across the organization that align with legal standards, internal policies, and industry association principles across all geographies. Grygiel is also responsible for executing against compliance obligations and creating leadership awareness around areas of potential risk for the company.

As a member of Amgen’s senior management team, Grygiel oversees administration of Amgen’s Corporate Responsibility and Compliance Committee of the Board in support of its committee chair. She also leads Amgen’s enterprise risk management program, chairs Amgen’s ESG council, and is a board member of the Amgen Foundation.

Before joining Amgen in 2015, Grygiel served as vice president of Compliance, Corporate and International at Allergan. Prior to Allergan, Grygiel held positions of increasing responsibility at Mylan Pharmaceuticals. Earlier in her career, Grygiel worked in the legal field with a focus on international law, business transactions, and export-control laws. She has also held in-house legal roles within the telecommunications industry in her home country, Argentina.

Grygiel has a law degree (J.D.) from Buenos Aires University and a Master of Laws degree (LL.M) from Georgetown University Law Center.